{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:28Z","timestamp":1792787908400,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Southern Medical University Nursing Research Special Fund","award":["Y2025015"],"award-info":[{"award-number":["Y2025015"]}],"id":[{"id":"https:\/\/ror.org\/01vjw4z39","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Dongguan Science and Technology of Social Development Program","award":["20221800906072"],"award-info":[{"award-number":["20221800906072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05197-1","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:14:37Z","timestamp":1784229277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy and safety of anticoagulation strategies in continuous renal replacement therapy: a real-world cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Qing","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LengZhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"5197_CR1","doi-asserted-by":"publisher","unstructured":"Bhatraju PK, Zelnick LR, Herting J, et al. Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med. 2019;199(7):863\u2013872. https:\/\/doi.org\/10.1164\/rccm.201808-1489OC.","DOI":"10.1164\/rccm.201808-1489OC"},{"key":"5197_CR2","doi-asserted-by":"publisher","unstructured":"Ostermann M, Bellomo R, Burdmann EA, et al. Controversies in acute kidney injury: conclusions from a kidney disease: improving global outcomes (KDIGO) conference. Kidney Int. 2020;98(2):294\u2013309. https:\/\/doi.org\/10.1016\/j.kint.2020.04.020.","DOI":"10.1016\/j.kint.2020.04.020"},{"issue":"1","key":"5197_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG, British Committee for Standards in Haematology. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24\u201333. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07600.x.","journal-title":"Br J Haematol"},{"key":"5197_CR4","unstructured":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. kdigo clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1\u2013138."},{"issue":"16","key":"5197_CR5","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, K\u00fcllmar M, Kindgen-Milles D, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324(16):1629\u201339. https:\/\/doi.org\/10.1001\/jama.2020.18618.","journal-title":"JAMA"},{"key":"5197_CR6","doi-asserted-by":"publisher","unstructured":"Liu C, Mao Z, Kang H, et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20:144. https:\/\/doi.org\/10.1186\/s13054-016-1299-0.","DOI":"10.1186\/s13054-016-1299-0"},{"key":"5197_CR7","doi-asserted-by":"crossref","unstructured":"van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol. 1996;7(1):145\u201350.","DOI":"10.1681\/ASN.V71145"},{"issue":"10","key":"5197_CR8","doi-asserted-by":"publisher","first-page":"e108737","DOI":"10.1371\/journal.pone.0108737","volume":"9","author":"YK Lee","year":"2014","unstructured":"Lee YK, Lee HW, Choi KH, Kim BS. Ability of nafamostat mesilate to prolong filter patency during continuous renal replacement therapy in patients at high risk of bleeding: a randomized controlled study. PLoS ONE. 2014;9(10):e108737. https:\/\/doi.org\/10.1371\/journal.pone.0108737.","journal-title":"PLoS ONE"},{"key":"5197_CR9","doi-asserted-by":"publisher","unstructured":"Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360\u20133392. https:\/\/doi.org\/10.1182\/bloodadvances.2018024489.","DOI":"10.1182\/bloodadvances.2018024489"},{"key":"5197_CR10","doi-asserted-by":"publisher","unstructured":"Gattas DJ, Rajbhandari D, Bradford C, et al. A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med. 2015;43(8):1622\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000001004.","DOI":"10.1097\/CCM.0000000000001004"},{"key":"5197_CR11","doi-asserted-by":"publisher","unstructured":"Zhou Z, Liu C, Yang Y, et al. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):222. https:\/\/doi.org\/10.1186\/s13054-023-04519-1.","DOI":"10.1186\/s13054-023-04519-1"},{"issue":"1","key":"5197_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/ndt\/gfq575","volume":"26","author":"GR Hetzel","year":"2011","unstructured":"Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transpl. 2011;26(1):232\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfq575.","journal-title":"Nephrol Dial Transpl"},{"key":"5197_CR13","doi-asserted-by":"publisher","unstructured":"Bai M, Zhou M, He L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098\u20132110. https:\/\/doi.org\/10.1007\/s00134-015-4099-0.","DOI":"10.1007\/s00134-015-4099-0"},{"key":"5197_CR14","doi-asserted-by":"publisher","unstructured":"Wang SV, Potteg\u00e5rd A, Crown W, et al. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: a good practices report of a joint ISPE\/ISPOR task force. Pharmacoepidemiol Drug Saf. 2023;32(1):44\u201355. https:\/\/doi.org\/10.1002\/pds.5601.","DOI":"10.1002\/pds.5601"},{"key":"5197_CR15","doi-asserted-by":"publisher","unstructured":"Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care. 2005;20(2):155\u201361. https:\/\/doi.org\/10.1016\/j.jcrc.2005.01.001.","DOI":"10.1016\/j.jcrc.2005.01.001"},{"key":"5197_CR16","doi-asserted-by":"publisher","unstructured":"Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009;37(2):545\u201352. https:\/\/doi.org\/10.1097\/CCM.0b013e3181953c5e.","DOI":"10.1097\/CCM.0b013e3181953c5e"},{"key":"5197_CR17","doi-asserted-by":"publisher","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy\u2014heparin or citrate? Crit Care. 2011;15(1):202. https:\/\/doi.org\/10.1186\/cc9358.","DOI":"10.1186\/cc9358"},{"key":"5197_CR18","doi-asserted-by":"publisher","unstructured":"Liu D, Zhao J, Xia H, et al. Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study. Eur J Med Res. 2024;29(1):72. https:\/\/doi.org\/10.1186\/s40001-024-01672-7.","DOI":"10.1186\/s40001-024-01672-7"},{"key":"5197_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jcrc.2020.03.002","volume":"56","author":"D Khadzhynov","year":"2020","unstructured":"Khadzhynov D, Deissler J, Bobonov O, et al. Intensive monitoring of post filter ionized calcium concentrations during CVVHD with regional citrate anticoagulation: A retrospective study. J Crit Care. 2020;56:114\u201320. https:\/\/doi.org\/10.1016\/j.jcrc.2020.03.002.","journal-title":"J Crit Care"},{"issue":"4","key":"5197_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x.","journal-title":"J Thromb Haemost"},{"key":"5197_CR21","doi-asserted-by":"publisher","unstructured":"Seto AC, Kenyon K, Wittkowsky AK. Discrepancies in identification of major bleeding events in patients taking warfarin. Pharmacotherapy. 2008;28(9):1098\u20131103. https:\/\/doi.org\/10.1592\/phco.28.9.1098.","DOI":"10.1592\/phco.28.9.1098"},{"key":"5197_CR22","doi-asserted-by":"publisher","first-page":"1442065","DOI":"10.3389\/fmed.2024.1442065","volume":"11","author":"C Hu","year":"2024","unstructured":"Hu C, Shui P, Zhang B, et al. How to safeguard the continuous renal replacement therapy circuit: a narrative review. Front Med (Lausanne). 2024;11:1442065. https:\/\/doi.org\/10.3389\/fmed.2024.1442065.","journal-title":"Front Med (Lausanne)"},{"key":"5197_CR23","doi-asserted-by":"publisher","unstructured":"Brain M, Winson E, Roodenburg O, McNeil J. Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis. BMC Nephrol. 2017;18(1):69. https:\/\/doi.org\/10.1186\/s12882-017-0495-8.","DOI":"10.1186\/s12882-017-0495-8"},{"issue":"22","key":"5197_CR24","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2482","volume":"32","author":"H Uno","year":"2014","unstructured":"Uno H, Claggett B, Tian L, Inoue E, Gallo P, Miyata T, et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014;32(22):2380\u20135. https:\/\/doi.org\/10.1200\/JCO.2014.55.2482.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5197_CR25","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65\u201370.","journal-title":"Scand J Stat"},{"key":"5197_CR26","doi-asserted-by":"crossref","unstructured":"Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer. 2000.","DOI":"10.1007\/978-1-4757-3294-8"},{"issue":"2","key":"5197_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/01.CCM.0000044502.14429.7B","volume":"31","author":"B Manns","year":"2003","unstructured":"Manns B, Doig CJ, Lee H, et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med. 2003;31(2):449\u201355. https:\/\/doi.org\/10.1097\/01.CCM.0000044502.14429.7B.","journal-title":"Crit Care Med"},{"key":"5197_CR28","doi-asserted-by":"publisher","unstructured":"Schilder L, Nurmohamed SA, Bosch FH, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care. 2014;18(4):472. https:\/\/doi.org\/10.1186\/s13054-014-0472-6.","DOI":"10.1186\/s13054-014-0472-6"},{"key":"5197_CR29","doi-asserted-by":"publisher","unstructured":"Karkar A, Ronco C. Prescription of continuous renal replacement therapy: a pathway to optimize therapy. Ann Intensive Care. 2020;10(1):32. https:\/\/doi.org\/10.1186\/s13613-020-00648-y.","DOI":"10.1186\/s13613-020-00648-y"},{"key":"5197_CR30","doi-asserted-by":"publisher","unstructured":"Shillan D, Sterne JAC, Champneys A, Gibbison B. Use of machine learning to analyse routinely collected intensive care unit data: A systematic review. Crit Care. 2019;23:284. https:\/\/doi.org\/10.1186\/s13054-019-2566-8.","DOI":"10.1186\/s13054-019-2566-8"},{"key":"5197_CR31","doi-asserted-by":"publisher","unstructured":"Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365\u20133370. https:\/\/doi.org\/10.1681\/ASN.2004110323.","DOI":"10.1681\/ASN.2004110323"},{"key":"5197_CR32","doi-asserted-by":"publisher","unstructured":"Zhang W, Bai M, Yu Y, et al. Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: A systematic review and meta-analysis. Semin Dial. 2021;34(3):196\u2013208. https:\/\/doi.org\/10.1111\/sdi.12956.","DOI":"10.1111\/sdi.12956"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05197-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:05:58Z","timestamp":1792001158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05197-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5197"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05197-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Nanfang Hospital (NFEC-2026-265) and was conducted in accordance with the Declaration of Helsinki. The Ethics Committee of Nanfang Hospital waived the requirement for informed consent due to the study\u2019s retrospective nature.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"607"}}